Research Article

High Baseline CD4 Count and Exclusive Breastfeeding Are Associated with Lower Rates of Mother to Child HIV Transmission in Northwestern Uganda: A Two-Year Retrospective Cohort Study

Table 2

Bivariate analysis of factors associated with MTCT at ARRH, Northwestern Uganda.

Variable MTCT along the EID cascade?TotalUnivariable logistic
regression analysis
-value
No (No., %)Yes (No., %)UOR (95% CI)

Overall270 (91.5)25 (8.5)295
Maternal age (years)
 Less or equals 3053 (85.5)9 (14.5)62Ref
 More than 30217 (93.1)16 (6.9)2330.43 (0.18–1.04)0.060
Parity (children ever born)
 One131 (92.2)11 (7.8)142Ref
 More than one139 (90.8)14 (9.2)1530.20 (0.52–2.74)0.666
Attended ANC during pregnancy
 No107 (85.6)18 (14.4)125Ref
 Yes163 (95.9)7 (4.1)1700.25 (0.10–0.63)0.003
Baseline WHO Clinical staging
 I & II232 (92.4)19 (7.6)251Ref
 III & IV38 (86.4)6 (13.6)441.93 (0.72–5.14)0.189
Baseline CD4 count (cells/ml)
 <35065 (83.3)13 (16.7)78Ref
 350–50045 (95.7)2 (4.3)470.22 (0.05–1.03)0.055
 >500160 (94.1)10 (5.9)1700.312 (0.13–0.75)0.009
Place of delivery
 Health facility192 (94.1)12 (5.9)204Ref
 Home78 (85.7)13 (14.3)912.67 (1.16–6.10)0.02
Mode delivery
 SVD233 (92.8)18 (7.2)251Ref
 Caesarean section37 (84.1)7 (15.9)442.45 (0.96–6.26)0.062
Nevirapine initiation after delivery
 Never at all22 (62.9)13 (37.1)35Ref
 After 6-weeks3 (100.0)0 (0.0)31
 From birth up to 6-weeks245 (95.3)12 (4.7)2570.08 (0.03–0.20)<0.001
Exclusive breastfeeding in first 6-months
 No33 (66.0)17 (34.0)50Ref
 Yes237 (96.7)8 (3.3)2450.06 (0.03–0.16)<0.001
Maternal use of ART
 ART naïve5 (62.5)3 (37.5)8Ref
 Received ART during labor and delivery6 (54.6)5 (45.4)111.39 (0.22–8.92)0.729
 On life-long ART259 (93.8)17 (6.2)2760.11 (0.02–0.50)0.004

Note. Percentages calculated as row percentages (n/N); ANC: antenatal care; AOR: adjusted odds ratio; ART: antiretroviral therapy; MTCT: mother to child transmission of HIV; NVP: Nevirapine; UOR: unadjusted odds ratio; Ref: reference category.